Schedule 13G ownership disclosure
SIGA PHARMACEUTICALS INC
Security class unavailable
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,730,852
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001662379-16-000002
- Form type
- SC 13G
- Filer
- Lewis John Latane IV
- CIK
- CIK 1662379
- Filed
- Jan 08, 2016
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership